AVXL

Anavex Life Scie

• Reuters·4d ago

  Anavex Life Sciences to present at Needham Virtual Healthcare Conference

• Dow Jones·03/31 12:49

  Anavex Life Sciences Is Maintained at Buy by D. Boral Capital

• Dow Jones·03/31 12:49

  Anavex Life Sciences Price Target Maintained With a $24.00/Share by D. Boral Capital

• TipRanks·03/31 10:38

  Reaffirming Buy on Anavex: Long-Term Value in Blarcamesine Outweighs Near-Term Regulatory Setbacks

• TipRanks·03/30 11:49

  Anavex gives update after blarcamesine marketing authorization withdrawal

• Benzinga·03/30 11:36

  Anavex Life Sciences Continues Dialogue With EMA To Advance Development Program Of Oral Blarcamesine In Early Alzheimer's Disease

• Reuters·03/30 11:33

  Anavex keeps EMA talks after withdrawing EU blarcamesine filing for early Alzheimer’s

• Reuters·03/30 11:30

  ANAVEX LIFE SCIENCES PROVIDES COMPREHENSIVE REGULATORY UPDATE

• Reuters·03/30 11:30

  ANAVEX LIFE SCIENCES CORP - CONTINUES DIALOGUE WITH EUROPEAN MEDICINES AGENCY ON ORAL BLARCAMESINE FOR EARLY ALZHEIMER'S DISEASE

• Reuters·03/27 11:42

  EMA'S CHMP: APPLICATION FOR INITIAL MARKETING AUTHORISATION OF BLARCAMESINE ANAVEX WAS WITHDRAWN.

• Dow Jones·03/26 18:52

  Anavex Life Sciences Is Maintained at Buy by D. Boral Capital

• Dow Jones·03/26 18:52

  Anavex Life Sciences Price Target Maintained With a $24.00/Share by D. Boral Capital

• TipRanks·03/25 20:36

  Anavex Withdraws EU Application for Blarcamesine in Alzheimer’s

• Reuters·03/25 20:08

  Anavex Life Sciences withdraws EU marketing application for blarcamesine; EMA review turns negative on CHMP feedback

• Benzinga·03/25 19:36

  Crude Oil Moves Lower; Cintas Raises FY2026 Forecast